How many insider trades does FilingIQ track for VYGR?

FilingIQ tracks 222 Form 4 insider transactions for VYGR (Voyager Therapeutics, Inc.), covering filings from Nov 10, 2015 onwards. 9 of those were filed in the last 90 days.

Are VYGR insiders net buyers or net sellers?

Across the full Form 4 history for VYGR, 9 transactions (4%) were open-market purchases and 116 (52%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does VYGR insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is VYGR in?

Voyager Therapeutics, Inc. (VYGR) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $209.33M.

VYGR insider trading

NasdaqGS Healthcare

Voyager Therapeutics, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

222

Last 90 days

Buys / sells

4% / 52%

Market cap

$209.33M

About Voyager Therapeutics, Inc.

Voyager Therapeutics, Inc., a biotechnology company, focuses on the human genetics for the cure of neurological diseases. The company's lead product candidate is VY7523, an anti-tau antibody program for the treatment of alzheimer's disease (AD). Its product pipeline includes VY1706, a tau silencing gene therapy in preclinical trial for the treatment of alzheimer's disease; SOD1 silencing gene therapy program for treating amyotrophic lateral sclerosis in preclinical trial; and vectorized anti-amyloid antibody early research program for the treatment of AD in preclinical trial. The company is also developing VY-FXN01 for treating friedreich's ataxia; and GBA1 gene replacement program to treat parkinson's disease. In addition, it provides research program for the treatment of Huntington's disease. The company has collaboration and license agreements with Alexion; AstraZeneca Ireland Limited; Novartis Pharma AG; and Neurocrine Biosciences, Inc. for the treatment of various other diseases of the central nervous system. Voyager Therapeutics, Inc. was incorporated in 2013 and is headquartered in Lexington, Massachusetts.

Company website: www.voyagertherapeutics.com

VYGR insider activity at a glance

FilingIQ has scored 222 insider transactions for VYGR since Nov 10, 2015. The most recent filing in our index is dated Apr 2, 2026.

Across the full history, 9 open-market purchases and 116 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on VYGR insider trades is 56.9/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live VYGR trades on FilingIQ Raw filings on SEC EDGAR

Latest VYGR Form 4 filings

PFREUNDSCHUH PETER P. Chief Financial Officer

S Oct 3, 2023

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for VYGR?: FilingIQ tracks 222 Form 4 insider transactions for VYGR (Voyager Therapeutics, Inc.), covering filings from Nov 10, 2015 onwards. 9 of those were filed in the last 90 days.
Are VYGR insiders net buyers or net sellers?: Across the full Form 4 history for VYGR, 9 transactions (4%) were open-market purchases and 116 (52%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does VYGR insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is VYGR in?: Voyager Therapeutics, Inc. (VYGR) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $209.33M.

Methodology & sources

Every VYGR insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.